Published on 02/12/2025

Domain Shift Across Sites: Parity and Exceptions

The integration of artificial intelligence (AI) and machine learning (ML) within Good Practice (GxP) analytics is reshaping pharmaceutical validation processes. This guide seeks to provide a comprehensive step-by-step tutorial on the validation of AI/ML models, with a particular focus on domain shift across sites, ensuring compliance with regulatory expectations under the US FDA, EMA, MHRA, and PIC/S guidelines.

Understanding AI/ML Model Validation

AI/ML model validation is crucial in the pharmaceutical industry, particularly when integrating these technologies in GxP environments. It ensures that models are robust, reliable, and accurate in their intended use.

• **Intended Use and Data Readiness**: Understanding the specific purpose of an AI/ML model is the first step in validation. This includes specifying the application within GxP contexts, such as clinical trials, patient monitoring, or manufacturing processes.
• **Bias and Fairness Testing**: Models must be assessed for biases that may affect their performance across different populations or datasets. Bias and fairness testing is critical to maintain ethical standards and regulatory compliance.
• **Model Verification and Validation (V&V)**: V&V processes involve verifying model outputs against established standards and validating that the model performs as intended.
• **Explainability (XAI)**: Explainability in AI models is vital for understanding the decision-making process of models, which aids in building trust among stakeholders.

Each of these components plays a significant role in ensuring compliance and building a framework conducive to successful model deployment in a regulated environment.

Step 1: Assessing Intended Use and Data Readiness

The first step is to define the intended use of the AI/ML model. Regulatory authorities emphasize the importance of aligning model performance with the specific applications it is designed to support. Clarifying the intended use enables better risk assessment and helps in establishing the necessary data readiness standards.

Defining Intended Use

Establishing the intended use involves answering these key questions:

• What specific problem is the model designed to solve?
• Who will be the end-user of the model’s outputs?
• What consequences might arise from model decisions?

The answers to these questions guide the entire validation process. In addition to defining the intended use, data readiness must be evaluated. This includes:

• **Data Quality**: Assessing whether the training and validation datasets are complete, relevant, and appropriately curated.
• **Data Governance**: Implementing robust data management systems to ensure data integrity and security. 21 CFR Part 11 compliance is essential for electronic records and signatures.
• **Data Documentation**: Maintaining detailed records of data sources, collection procedures, and any preprocessing undertaken to ensure transparency and traceability.

Step 2: Bias and Fairness Testing

Bias in AI/ML models can lead to non-compliance and unethical decisions, therefore addressing this is critical. The goal of bias and fairness testing is to analyze how the model performs with diverse populations.

Strategies for Bias Assessment

To conduct an effective bias assessment:

• **Identify Potential Bias**: Understand the sources of bias that can affect model performance, including sample imbalances and label inaccuracies.
• **Test Across Different Datasets**: Use various datasets to evaluate model performance across different demographic groups, ensuring equitable performance.
• **Utilize Fairness Metrics**: Implement fairness metrics such as equal opportunity and demographic parity to quantify the level of bias and fairness.

Regulatory guidelines recommend including bias assessments as part of the model documentation to demonstrate compliance with ethical standards.

Step 3: Model Verification and Validation (V&V)

Verification and validation are foundational to the overall AI/ML model validation process. Verification ensures that the model is constructed correctly, while validation confirms that it meets the specified requirements and functions as intended in its operating environment.

Verification Process

• **Code Review**: Perform rigorous code inspections to identify errors or deviations from standards.
• **Unit Testing**: Test individual components of the model to check for correct functionality.
• **Integration Testing**: Assess how various components of the model interact as a cohesive unit.

Validation Process

• **Performance Testing**: Validate model performance against benchmarks and expected outcomes.
• **Stress Testing**: Analyze model performance under extreme conditions to evaluate robustness.
• **Longitudinal Studies**: Conduct studies to observe the model’s performance over extended periods, particularly in the context of drift monitoring and re-validation.

Documentation of the verification and validation processes is crucial for maintaining a trail that can be audited by regulatory authorities. This aligns with the principles outlined in GAMP 5 for software and automated systems validation.

Step 4: Explainability (XAI)

Explainable AI (XAI) focuses on the transparency of AI decision-making processes. Regulatory bodies require that models not only perform accurately but also provide understandable reasoning for their outputs.

Techniques for Enhancing Explainability

• **Model-Agnostic Methods**: Use methods such as SHAP (SHapley Additive exPlanations) or LIME (Local Interpretable Model-Agnostic Explanations) to explain model predictions without delving into the internal workings of the model.
• **Algorithmic Transparency**: Employ simpler models when appropriate, as they tend to be more interpretable compared to complex neural networks.
• **Documentation of Decision Processes**: Keep detailed records of how data inputs translate into decision outputs, fostering a better understanding of model logic.

Ultimately, effective explainability contributes to trust in AI systems, providing reassurance to stakeholders and facilitating regulatory compliance.

Step 5: Monitoring for Drift and Re-Validation

Model performance can degrade over time due to shifts in the underlying data distribution. Therefore, implementing a robust monitoring framework is essential for early detection of drift and necessitates re-validation of the model.

Implementation of Drift Monitoring

• **Threshold Setting**: Establish thresholds for model performance metrics that trigger alerts when deviations occur.
• **Continuous Evaluation**: Regularly assess models against new incoming data to identify drift trends.
• **Feedback Mechanisms**: Integrate mechanisms to capture user feedback on model outputs to improve ongoing model training and validation.

When significant drift is detected, a re-validation process should be initiated to ensure the model continues to meet its intended use requirements. Documentation should encompass the drift analysis and validation outcomes to provide clarity and transparency.

Step 6: Documentation and Audit Trails

Comprehensive documentation is a critical component of AI/ML model validation, ensuring that all processes, decisions, and evaluations are traceable and verifiable. Regulatory authorities emphasize the importance of maintaining complete records, especially under guidelines such as Annex 11 and GAMP 5.

Key Documentation Practices

• **Model Development Records**: Document the entire development lifecycle including methodologies, data sources, and model training processes.
• **Test Cases and Results**: Maintain records of all test cases, results, and any corrective actions taken during the verification and validation phases.
• **Change Control**: Implement a change control system to track modifications to the model and its environment.

A thorough documentation process not only facilitates compliance but also serves as a valuable resource for continuous improvement initiatives and future audits.

Step 7: AI Governance and Security

Establishing robust AI governance frameworks is critical to effectively manage risks associated with AI/ML model deployment. This includes ensuring data security and compliance with relevant regulatory standards.

Best Practices for AI Governance

• **Policy Development**: Create comprehensive policies outlining the governance framework for AI/ML projects.
• **Compliance Checks**: Regularly review compliance with governance policies to identify gaps and areas for improvement.
• **Training and Awareness**: Conduct training sessions for all stakeholders regarding AI governance, model use, and regulatory expectations.

By adhering to these best practices, organizations can mitigate risks and enhance accountability within their AI/ML programs, leading to greater compliance with regulatory expectations.

Conclusion

The validation of AI/ML models within the pharmaceutical arena is a multifaceted endeavor that requires careful consideration of regulatory expectations and best practices. By following the structured steps outlined in this tutorial, professionals can ensure that their models are robust, compliant, and capable of delivering accurate and fair outcomes.

The continuing evolution of AI technologies and their integration into pharmaceutical processes will necessitate ongoing education, adaptation, and vigilance to maintain compliance and uphold ethical standards. By proactively addressing aspects such as intended use, data readiness, bias testing, model V&V, explainability, drift monitoring, documentation, and robust governance, professionals can effectively navigate the complexities of AI/ML model validation.